00:00In regional Australia, there's limited access generally to GPs and the training for GPs
00:09can miss out on immunopause care. So often women are finding that they're unable to get
00:14the care that they need and the medications that they would really benefit from can be
00:19limited with Australia as well. It's been a real problem. So I think in terms of GPs,
00:25you're really reliant on a limited number of GPs. You're really relying on those GPs having good
00:32knowledge and confidence in managing immunopause, which is not necessarily the case across all of
00:37our training. So that's the first part. And then access to specialist care to support those GPs
00:42is also limited. So that's the immediate difference, I say. And in the medications,
00:48in terms of oestrogen availability, that's been a difficulty across all of Australia for a number
00:53of years. So that's not limited to regional areas, but often our pharmacies have less access to some
00:59of these medications as the city pharmacies. So that can be another level of disadvantage for regional women.
Comments